Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Novel Patient-Reported Quality of Life Metric "Prolac-10" for Patients Undergoing Medical Therapy for Prolactinoma

NCT04106531 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT04106531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04106531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Novel Patient-Reported Quality of Life Metric "Prolac-10" for Patients Undergoing Medical Therapy for Prolactinoma
Lead sponsor
Ohio State University
Phase
Observational
Overall status
Terminated
Start date
October 15, 2019
Completion date
June 13, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pituitary tumor, prolactin-producing pituitary tumor, prolactinoma, prolactinoma macroadenoma, prolactinoma microadenoma